Reference is made notice published by Bionor Pharma ASA (OSE:BIONOR) 23 October 2013 regarding completion of subsequent offering of new shares with gross proceeds of NOK 20.6 million.
The share capital increase was registered in the Norwegian Register of Business Enterprises (Foretaksregisteret) 5 November 2013. The Company's new share capital after registration is NOK 56,456,587 comprising 225,826,348 shares with a par value of NOK 0.25.
Bionor Pharma ASA
Synne H Røine
CFO
Tel +47 99 22 98 92
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act).